Recombinant interleukin-2 pre-treatment increases anti-tumor response to paclitaxel by affecting lung P-glycoprotein expression on the Lewis lung carcinoma

Hosten, Benoît; Challuau, Désiré; Gil, Sophie; More

Anti-Cancer Drugs . 17(2):195-199, February 2006.